News

News

Supergood Superfoods – Professor Avni Sali’s latest monthly article for The Melbourne Review

February 18, 2013

In latest issue of the The Melbourne Review Professor Avni Sali’s monthly article titled: ‘Supergood Superfoods for Optimal Health’ delves into the world of the ‘Super Food’, their ability to improve health outcomes and the importance of including them in…

Read more...

In the news – Shepparton News Feature

February 5, 2013

NIIM has recently been featured in the Shepparton News. For more news from the Shepparton region visit Shepparton News

Read more...

Antioxidants and Cancer Prevention

January 29, 2013

In a article published by the Orthomolecular Medicine News Service Steve Hickey, PhD writes on research demonstrating how Antioxidants can be used to prevent and potentially cure Cancer. Antioxidants Prevent Cancer and Some May Even Cure It Commentary by Steve…

Read more...

NIIM responds to latest Vitamin controversy

January 15, 2013

You may have seen the recent articles in the media: “Vitamins could hinder, not help cancer fight”, by Nick Collins on a research paper written by Jim Watson, which appeared in The Age, page 7, on 10 Jan 2013 as…

Read more...

In the news – Dr Karin Ried’s Garlic Trials

January 11, 2013

A recent Study lead by Dr Karin Ried has studied Garlic, it’s blood pressure-lowering properties and it’s potential use as a treatment for Hypertension, a medical condition that affects about 30% of adults worldwide. Dr Karin Ried’s trial assessed the…

Read more...

In the news – NIIM Hyperthermia Launch

September 12, 2012

On Wednesday 29th August, the official Hyperthermia Launch was held at NIIM. Around 40 people, plus Media were in attendance. The sun shone upon us as we marked this special occasion in a fitting tribute to the Bardas Family Foundation….

Read more...

New treatment option offering hope to cancer sufferers at NIIM

September 5, 2012

The recently launched NIIM 2012 Hyperthermia Study, Australia’s first study examining the effects of Hyperthermia as an adjunctive cancer treatment is anticipated to replicate the high success rates of previous studies with minimal risk, thereby pioneering another tool in the…

Read more...

1 7 8 9